Relapse- and Immunosuppression-Free Survival after Hematopoietic Stem Cell Transplantation: How Can We Assess Treatment Success for Complex Time-to-Event Endpoints?-Reference-Cited by-同舟云学术

Relapse- and Immunosuppression-Free Survival after Hematopoietic Stem Cell Transplantation: How Can We Assess Treatment Success for Complex Time-to-Event Endpoints?

Published:2020-05 Issue:5 Volume:26 Page:992-997
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Bluhmki Tobias,Schmoor Claudia^ORCID,Finke Jürgen,Schumacher Martin,Socié Gérard,Beyersmann Jan

Funder

Deutsche Forschungsgemeinschaft

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference46 articles.

1. Pitfalls of using composite primary end points in the presence of competing risks;Mell;J Clin Oncol,2010

2. Suggestions on the use of statistical methodologies in studies of the European group for blood and marrow transplantation;Iacobelli;Bone Marrow Transplant,2013

3. Failure-free survival after initial systemic treatment of chronic graft-versus-host disease;Inamoto;Blood,2014

4. Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation;Holtan;Blood,2015

5. Multi-state analysis illustrates treatment success after stem cell transplantation for acute myeloid leukemia followed by donor lymphocyte infusion;Eefting;Haematologica,2016

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factors for graft-versus-host-disease after donor lymphocyte infusion following T-cell depleted allogeneic stem cell transplantation;Frontiers in Immunology;2024-03-13

2. A di-electrophoretic simulation procedure of iron-oxide micro-particle drug attachment system for leukemia treatment using COMSOL software: a potential treatment reference for LMICs;Frontiers in Medical Technology;2023-10-12

3. Feasibility, safety, and efficacy of early prophylactic donor lymphocyte infusion after T cell-depleted allogeneic stem cell transplantation in acute leukemia patients;Annals of Hematology;2023-03-07

4. Inferences for current chronic graft-versus-host-disease free and relapse free survival;BMC Medical Research Methodology;2022-12-13

5. The added value of multi‐state modelling in a randomized controlled trial: The HOVON 102 study re‐analyzed;Cancer Medicine;2021-12-24